Merck & Co Inc

NYSE: MRK
$102.89
+$1.27 (+1.2%)
Real Time Data Delayed 15 Min.

MRK Articles

November 28, 2016: Markets opened lower Monday after a long weekend of eating and shopping. There was no economic news of note, so this may just be a pause in an equity price run-up that has been on...
The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the selected pharmaceutical stocks.
November 18, 2016: Markets opened higher Friday but the good vibe did not last. The energy sector posted the best gain while the healthcare sector fared worst. As we head into the holiday week, and...
November 16, 2016: Markets opened lower Wednesday but only the Nasdaq Composite has managed to boost itself into positive territory. The tech sector was the day’s leading gainer, but was more than...
Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these selected pharmaceutical stocks.
November 9, 2016: Markets opened lower again Wednesday following the unexpected results of Tuesday’s election. Overnight DJIA futures dropped some 800 points at one point, but equities gained...
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.
24/7 Wall St. tracked three unusual research patterns emerging out of the 30 Dow stocks in the week ending October 28.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Groupon, Merck, News Corp, Walt Disney, Vonage and Western Digital.
The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Merck is scheduled to release its third-quarter earnings report after before the markets open on Tuesday.
Americans generally would like to spend less money on health care. One way that this can be and will be accomplished is through the continued use and expanded use of generic drugs.
October 17, 2016: Markets opened slightly higher Monday, but that didn’t last long. Equities traded in a fairly narrow range all day as we head into another week that is likely to be dominated by...
Here were six solid Buy or equivalent ratings issued in Apple, Merck and other blue chip stocks during the week of October 14.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Charles Schwab, Merck, Nokia, Viacom, Waste Management and Windstream.